Two experts demonstrated how proteomics measures aging pace
The study showed that semaglutide caused cardiometabolic and inflammatory protein changes that persisted after the drug was stopped.
- Field
- ageing and longevity
- What they did
- Researchers discuss using ultra-sensitive proteomics to measure aging speed and evaluate the impact of interventions, such as the drug semaglutide, on biological processes.
- Why it matters
- This could aid clinical trials by allowing quick screening of potential interventions using data from completed studies with stored samples.
#semaglutide#aging#proteomics#clinical trial#inflammation



